| 1 |
Kern FH, Schell RM, Greeley WJ.Cerebral monitoring during cardiopulmonary bypass in children[J]. J Neurosurg Anesthesiol, 1993, 5(3): 213-217.
|
| 2 |
Gwak YS, Kang J, Unabia GC, et al.Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats[J]. .Exp Neurol, 2012, 234(2): 362-372.
|
| 3 |
Zoltewicz JS, Scharf D, Yang B, et al.Characterization of antibodies that detect human GFAP after traumatic brain injury[J]. Biomark Insights, 2012, 7: 71-79.
|
| 4 |
Nylén K, Ost M, Csajbok LZ, et al.Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome[J]. J Neurol Sci, 2006, 240(1-2): 85-91.
|
| 5 |
邓平，徐小虎，祝家镇．大白鼠脑干损伤后脑组织中GFAP免疫组化改变的初步研究[J]. 法医学杂志，1996，V0(4)：206-208.
|
| 6 |
Rappold T, Laflam A, Hori D, et al.Evidence of an association between brain cellular injury and cognitive decline after non-cardiac surgery[J]. Br J Anaesth, 2016, 116(1): 83-89.
|
| 7 |
方敏，黄绮薇，方阅．妊娠合并糖尿病母亲新生儿脐血S100B蛋白、NSE、MBP水平及NBNA相关性研究[J]．中国医药导刊，2014，16(8)：1253-1257.
|
| 8 |
Laatsch RH, Kies MW, Gordon S, et al.The encephalomyelitic activity of myelin isolated by ultracentrifugation [J]. J Exp Med, 1962, 115(4): 777-778.
|
| 9 |
Hergenroeder GW, Redell JB, Moore AN, et al. Biomarkers in the clinical diagnosis and management of traumatic brain injury[J]. Mol Diagn Ther, 2008, 12(6): 345-358.
|
| 10 |
张林享，张旋，张霞．高压氧治疗新生儿缺氧缺血脑病血清NSE、MBP的变化[J]．中国实用神经病杂志，2007，10(8)：9-11.
|
| 11 |
苏永棉．血清MBP、S100B的变化在新生儿窒息中的临床意义[J]．中国当代医药，2012，19(10)：53-54.
|
| 12 |
陈俊，何国厚，黎华，等．急性脑梗死患者髓鞘碱性蛋白动态检测的临床意义[J]．湖北医学院学报，2005，24(2)：77-79.
|
| 13 |
Berger RP, Beers SR, Richichi R, et al.Serum biomarker concentrations and outcome after pediatric traumatic brain injury [J]. J Neurotrauma, 2007, 24(12): 1793-1801.
|
| 14 |
Urrea C, Castellanos DA, Sagen J, et al. Widespread cellular proliferation and focal neurog-enesis after traumatic brain injury in the rat [J]. Restor Neurol Neurosci, 2007, 25(1): 65-76.
|
| 15 |
Baker AJ, Rhind SG, Morrison LJ, et al.Resuscitation with hypertonic saline-dextran educes serum biomarker levels and correlates with outcome in severe traumatic brain injury patients [J]. J Neurotrauma, 2009, 26(8): 1227-1240.
|
| 16 |
Gyorgy A, Ling G, Wingo D, et al. Time-dependent changes in serum biomarker levels after blast traumatic brain injury [J]. J Neurotrauma, 2011, 28(6): 1121-1126.
|
| 17 |
Royds JA, Taylor CB, Timperley WR.Enolase isoenzymes as diagnostic markers.Neuropathol Appl Neurobiol, 1985, 11(1): 1-16 .
|
| 18 |
靳国伟，韩世波，陈跃平．神经元特异性烯醇化酶的临床应用研究进展[J]．中国临床神经外科杂志，2013，18(3)：189-191.
|
| 19 |
王琨，李彦敏．NSE、S-100β蛋白与脑损伤关系的研究[J]．脑与神经疾病杂志2009，17(5)：396-398.
|
| 20 |
Scarna H, Delafossa B, Steinberg R, et al.Neuron-specifice nolase as a marker of neuronal lesions during various comas in man[J]. Neurochemnt, 1982, 4(5): 405-411.
|
| 21 |
Cheng F, Yuan Q, Yang J, et al. The Prognostic Value of Serum Neuron-Specific Enolase in Traumatic Brain Injury: Systematic Review and Meta-Analysis[J]. PLoS One, 2014, 9(9): e106680.
|
| 22 |
Gross J, Ungethüm U, Andreeva N, et al.Glutamate induced effluxof-protein, neuron-specific enolase and lactate dehydrogenasefrom a mesencephalic cell culture[J]. Eur J Clin Chem Clin Biochem, 1996, 34(4): 305-310.
|
| 23 |
Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases[J]. Stroke. 1994, 25(3): 558-565.
|
| 24 |
Yamazaki Y, Yada K, Morii S, et al.Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury[J]. Surg Neurol, 1995, 43 (3): 267 -271.
|
| 25 |
谢基华. NSE在高热惊厥患儿血清及脑脊液中的表达水平及临床意义[J]．江西医药，2016 ，51(7)：692-693.
|
| 26 |
杨俊梅．新生儿缺氧缺血性脑病血清和脑脊液NSE变化的临床意义[J]．中国实用神经疾病杂志，2012，15(1)：70-72.
|
| 27 |
Büttner T, Weyers S, Postert T, et al.S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction [J]. Stroke, 1997, 28(10): 1961-1965.
|
| 28 |
Woertgen C, Rothoerl RD.Serum S-100B protein in severe head injury[J]. Neurosurgery, 2000, 46(4): 1026-1027.
|
| 29 |
Ben Abdesselam O, Vally J, Adem C, et al.Reference values for serum S100β protein depend on the race of individuals[J]. Clin Chem, 2003, 49(5): 836-837.
|
| 30 |
RaabeA, KopetschO, GrossU, et al.Measurements of serum S-100B protein: effects of storage time and temperature on preanalyticalst ability[J]. Clin Chem Lab Med, 2003, 41(5): 700-703.
|
| 31 |
Hårdemark HG, Ericsson N, Kotwica Z, et al.S100B proS-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damagetein and neuron-specific enlace in CSF after experimental traumaticor focal ischemic brain damage[J]. J Neurosurg, 1989, 71(5 Pt 1): 727-731.
|
| 32 |
Person L, Hard mark HG, Gustafson J, et al.S-100 protein uron-specific enlace in cerrebrospinal fluid and serum: markers of cell damage in human central nervous system[J]. Stoke, 1987, 18: 911-918.
|
| 33 |
Koh SX, Lee JK.S100B as a marker for brain damage and blood-brain barrier disruption following exercise[J]. Sports Med, 2014, 44(3): 369-385.
|
| 34 |
Jin X, Chen Z, Liu X, et al.The expression of endothelial barrier antigen(EBA)and S100β in the rat parietal cortex following brain irradiation [J]. Brain Res, 2014, 1558(17): 84-89.
|
| 35 |
Chiu PS, Lai SC.Matrix metalloproteinase-9 leadsto blood-brain barrier leakage in mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis[J]. Acta Trop, 2014, 140: 141-150.
|
| 36 |
Bargerstock E, Puvenna V, Iffland P, et al.Is peripheral immunity regulated by blood-brain barrier permeability changes[J]. PloS One, 2014, 9(7): e101477.
|
| 37 |
潘之光，秦嘉倩，吴炯，等．S100β蛋白在血脑屏障损伤评估中的应用价值[J]．检验医学，2016，31(3)：212-216.
|
| 38 |
Kleindienst A, Schmidt C, Parsch H, et al.The Passage of S100β from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity[J]. Cardiovasc Psychiatry Neurol, 2010, 2010(2090-0163): 801295.
|
| 39 |
Büttner T, Weyers S, Postert T, et al.S100 protein: sellurnmarker of focal brain darrlage after iSchemic territorial McA infarction[J]. Stroke, 1997, 28(10): 196l-1965.
|
| 40 |
Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring[J]. Restor Neurol Neurosci, 2003, 21(3-4): 177-190.
|
| 41 |
Rothermundt M, Peters M, Prehn JH, et al.S100B in brain damage and neurodegeneration[J]. Microsc Res Tech, 2003, 60(6): 614-632.
|
| 42 |
Beer C, Blacker D, Bynevelt M, et al.Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke[J]. J Neuroinflammation, 2010, 7(1): 71-76.
|
| 43 |
Wainwright MS, Craft JM, Griffin WS, et al.Increased susceptibility of S100β transgenic mice to perinatal hypoxia-ischemia[J]. Ann Neurol, 2004, 56(1): 61-67 .
|
| 44 |
Foerch C, Singer OC, Neumann-Haefelin T, et al.Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction [J]. Arch Neurol, 2005, 62(7): 1130-1134.
|
| 45 |
Kazmierski R, Michalak S, Wencel-Warot A, et al.Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients[J]. Neurology, 2012, 79(16): 1677-1685 .
|
| 46 |
Goyal A, Failla MD, Niyonkuru C, et al.S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury[J]. J Neurotrauma, 2013, 30(11): 946-957.
|
| 47 |
孟祥武，唐洲平，唐荣华．实验性脑出血后血S-100B动态变化规律研究[J]．湖北民族学院学报(医学版)，2009，26(3)：1-3.
|
| 48 |
Vos PE, van Gils M, Beems T, et al.Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity[J]. Eur J Neurol, 2006, 13(6): 632-638.
|
| 49 |
王小蓉，杜晓渝，陈娅，等．S100B检测对急性脑出血患者临床预后的评估价值研究[J]．临床研究，2013 ，10(15)：60-63.
|
| 50 |
翟杰，徐淑祝，崔吉俊，等．精神分裂症血浆S100B蛋白测定及临床意义探讨[J]．精神医学杂志，2008，21(4)：261-263.
|
| 51 |
Schroeter ML, Abdul-Khaliq H, Frühauf S, et al.Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia[J]. Schizo phr Res, 2003, 62(3): 231 -236.
|
| 52 |
Rothermundt M, Ponath G, Glaser T, et al.S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia[J]. Neuro psychopharmacology, 2004, 29(5): 1004-1011.
|
| 53 |
Chaves ML, Camozzato AL, Ferreira ED, et al.Serum levels of S100B and NSE proteins in Alzheimer’s disease patients[J]. J Neuroiflamation, 2010, 7(6): 110-116.
|
| 54 |
Green AJ, Thompson EJ, Stewart GE, et al.Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease[J]. J Neurol Neurosurg Psychiatry, 2001, 70(6): 744-748 .
|
| 55 |
Florio P, Michetti F, Bruschettini M, et al. Amniotic fluid S100B protein in mid-gestation and in traurer inefetal death[J]. Lancet, 2004, 364(9439): 270-272.
|
| 56 |
Shoskes DA, Zei tlin SI.Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis[J]. Prostate Cancer Prostatic Dis, 1999, 2(3): 159-162.
|
| 57 |
Schenatto CB, Xavier RM, Bredemeier M, et al.Raised serum S100B protein levels in neuropsychiatric lupus[J]. Ann Rheum Dis, 2006, 65(6): 829-831.
|
| 58 |
马宇洁，杨兴易，林兆奋，等．心肺复苏后大鼠血清神经元特异性烯醇化酶、S100β蛋白对脑损伤诊断的价值[J]．中华急诊医学杂志，2006，15(4)：335-337.
|
| 59 |
陈谦学，胡克琦，叶应湖，等．脑死亡患者血清神经元特异性烯醇化酶的变化[J]．中华实验外科杂志，2003，20(8)：693-694.
|
| 60 |
Brvar M, Mozina M, Osredkar J, et al.Prognostic value of S100B protein in carbon monoxide-poisoned rats[J]. Crit Care Med, 2004, 32(10): 2128-2130.
|
| 61 |
Brvar M, Mozina H, Osredkar J, et al.S100B protein in carbon monoxide poisoning: a pilot study[J]. Resuscitation, 2004, 61(3): 357-360.
|